Reference number : 236-2011-2012-Q1-00185, amendment number : , agreement type : G, recipient legal name : WEINFELD, Michael, recipient country : CA, recipient province : AB, recipient city : Edmonton, recipient postal code : T6G 2E1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 357058.0, agreement start date : 2011-10-01, agreement end date : 2014-09-30, description english : Preclinical evaluation of polynucleotide kinase/phosphatase as a therapeutic target., description french : Preclinical evaluation of polynucleotide kinase/phosphatase as a therapeutic target., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2011-12 to 2014-15), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2011-12 à 2014-15), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada